Results 141 to 150 of about 5,206,853 (166)

Molecular and pharmacodynamic insights into β-lactam therapy for high-inoculum <i>Enterobacter cloacae</i> complex infections. [PDF]

Antimicrob Agents Chemother
Kunz Coyne AJ, Gray R, May E, Curry H, Slain N, Delcher C, Shin E.   +6 more
europepmc   +1 more source

Rapid prediction of antibiotic resistance in <i>Enterobacter cloacae</i> complex using whole-genome and metagenomic sequencing. [PDF]

mSystems
Pan F, Han P, Wu Q, Hou W, Rao G, Ma Z, Weng W, Zhang H.   +7 more
europepmc   +1 more source

Clinical characteristics, molecular epidemiology and mechanisms of colistin heteroresistance in <i>Enterobacter cloacae</i> complex. [PDF]

Front Cell Infect Microbiol
Wei C, Wu J, Zhang J, Liang Y, Yu K, Liao M, Liang X, Wang J, Long W, Wang J, Chen S, Yang Y, Gong X, Li J, Zhang X.   +14 more
europepmc   +1 more source

Prevalence and genetics of cefepime resistance among the AmpC-producing organisms <i>Citrobacter freundii</i> complex, <i>Enterobacter cloacae</i> complex, and <i>Klebsiella aerogenes</i>. [PDF]

Antimicrob Agents Chemother
Schrader SM, Pearson Z, Taffner S, Kanjilal S, Pecora ND.   +4 more
europepmc   +1 more source

High prevalence of carbapenem-resistant <i>Enterobacter cloacae</i> complex in a tertiary hospital over a decade. [PDF]

Microbiol Spectr
Cai S, Quan J, Wang Z, Hu H, Han X, Jiang Y, Yang Q, Yu Y, Zhou Z.   +8 more
europepmc   +1 more source